Accuracy of Detection and Grading of Diabetic Retinopathy and Diabetic Macular Edema Using Teleretinal Screening

被引:23
|
作者
Date, Rishabh C. [1 ,2 ]
Shen, Kevin L. [3 ]
Shah, Beena M. [3 ]
Sigalos-Rivera, Mara A. [3 ]
Chu, Yvonne, I [1 ,2 ]
Weng, Christina Y. [1 ,2 ]
机构
[1] Baylor Coll Med, Dept Ophthalmol, Houston, TX USA
[2] Ben Taub Gen Hosp, Dept Ophthalmol, Harris Hlth Syst, Houston, TX USA
[3] Baylor Coll Med, Sch Med, Houston, TX USA
来源
OPHTHALMOLOGY RETINA | 2019年 / 3卷 / 04期
关键词
D O I
10.1016/j.oret.2018.12.003
中图分类号
R77 [眼科学];
学科分类号
100212 ;
摘要
Purpose: To determine the accuracy of a county teleretinal screening program of detecting referable diabetic retinopathy (DR) and treatable diabetic macular edema (DME), as well as to evaluate patient compliance with clinic follow-up after referral from teleretinal screening. Design: Retrospective observational study. Participants: Patients in the Harris Health System (HHS, Houston, TX) older than 18 years of age who underwent teleretinal screening between July 2014 and July 2016. Methods: Teleretinal imaging (TRI) consisting of single-field 45-degree nonmydriatic color fundus photography with referral thresholds of severe nonproliferative DR, proliferative DR, and significant DME. Teleretinal imaging results for all referred subjects were obtained and cross-referenced with dilated fundus examination findings with regard to DR severity and the presence of DME. Follow-up status was also noted. Subjects underwent OCT if deemed necessary by the examining specialist. Agreement between TRI and dilated fundus examination (DFE) findings was determined by calculating the Cohen k coefficient. Main Outcome Measures: The primary outcome measure is agreement between TRI results and DFE findings with regard to DR severity and the presence of DME. The secondary outcome measure is compliance with follow-up. Results: Of 1767 patients who were screened and referred for clinical examination, 935 (52.9%) attended their clinic appointment. Overall agreement between DFE and TRI was moderate (weighted k 0.45) in terms of DR severity. There was agreement within one DR severity level in 86.2% of patients. The positive predictive value for detecting referable disease was 71.3%. Of patients referred for DME, 30.4% were deemed to have treatable DME. Conclusions: The HHS teleretinal screening program demonstrates a high level of accuracy in the detection and classification of referable DR, but a lesser degree of accuracy in the detection of treatable DME. Only slightly more than half of participants were compliant with follow-up after a TRI referral. This large-scale study provides insight into the utility of teleretinal screening in a county health care system. (C) 2018 by the American Academy of Ophthalmology.
引用
收藏
页码:343 / 349
页数:7
相关论文
共 50 条
  • [41] CANet: Cross-Disease Attention Network for Joint Diabetic Retinopathy and Diabetic Macular Edema Grading
    Li, Xiaomeng
    Hu, Xiaowei
    Yu, Lequan
    Zhu, Lei
    Fu, Chi-Wing
    Heng, Pheng-Ann
    IEEE TRANSACTIONS ON MEDICAL IMAGING, 2020, 39 (05) : 1483 - 1493
  • [42] Effect of Visual Impairment on Teleretinal Imaging for Diabetic Retinopathy Screening
    Rico-Sergado, Laura
    Perez-Canales, Jose L.
    Perez-Santonja, Juan J.
    OPHTHALMIC SURGERY LASERS & IMAGING RETINA, 2016, 47 (01): : 42 - 48
  • [43] Surgical Innovations in the Treatment of Diabetic Macular Edema and Diabetic Retinopathy
    Maria H. Berrocal
    Luis A. Acaba
    Megan L. Chenworth
    Current Diabetes Reports, 2019, 19
  • [44] Novel imaging biomarkers in diabetic retinopathy and diabetic macular edema
    Markan, Ashish
    Agarwal, Aniruddha
    Arora, Atul
    Bazgain, Krinjeela
    Rana, Vipin
    Gupta, Vishali
    THERAPEUTIC ADVANCES IN OPHTHALMOLOGY, 2020, 12
  • [45] Novel Treatments for Diabetic Macular Edema and Proliferative Diabetic Retinopathy
    Nhon T. Le
    Zachary A. Kroeger
    Weijie Violet Lin
    Arshad M. Khanani
    Christina Y. Weng
    Current Diabetes Reports, 2021, 21
  • [46] Anti-VEGF in diabetic retinopathy and diabetic macular edema
    Habbu, Karishma
    Singh, Rishi P.
    EXPERT REVIEW OF OPHTHALMOLOGY, 2016, 11 (06) : 443 - 451
  • [47] Laser Therapy in the Treatment of Diabetic Retinopathy and Diabetic Macular Edema
    Lesley A. Everett
    Yannis M. Paulus
    Current Diabetes Reports, 2021, 21
  • [48] Current Treatments and Innovations in Diabetic Retinopathy and Diabetic Macular Edema
    Gonzalez-Cortes, Jesus H.
    Martinez-Pacheco, Victor A.
    Gonzalez-Cantu, Jesus E.
    Bilgic, Alper
    de Ribot, Francesc March
    Sudhalkar, Aditya
    Mohamed-Hamsho, Jesus
    Kodjikian, Laurent
    Mathis, Thibaud
    PHARMACEUTICS, 2023, 15 (01)
  • [49] Latent Diabetic Macular Edema in Chinese Diabetic Retinopathy Patients
    Bai, Xue
    Hua, Rui
    FRONTIERS IN MEDICINE, 2021, 8
  • [50] Laser Therapy in the Treatment of Diabetic Retinopathy and Diabetic Macular Edema
    Everett, Lesley A.
    Paulus, Yannis M.
    CURRENT DIABETES REPORTS, 2021, 21 (09)